ã€ãã«ã¡ã¯ããŒã«
ã€ãã«ã¡ã¯ããŒã«ïŒã€ãã«ã¡ã¯ãã³ïŒ
ã€ãã«ã¡ã¯ããŒã«ã¯ãæå¹æåã€ãã«ã¡ã¯ãã³ãç¹åŸŽãšããè¬å€ã§ãå€æ§ãªå¯çè«ææçã«å¯Ÿããå¹æãèªããããŠããŸãããã®å»è¬åã¯ãç¹ã«ãªã³ã³ã»ã«ã«çïŒæ²³å·ç²ç®ïŒãã¹ããã³ã¬ã€ãã€ãã¹çãç¥ç¬ïŒããããïŒãã·ã©ãçã®æ²»çã«éèŠã§ããã€ãã«ã¡ã¯ãã³ã¯å¯çè«ã®ç¥çµãšçèã®æ©èœã«å¹²æžãã麻çºãããŠæçµçã«æ»ã«è³ãããŸããæè«ã ãã§ãªã幌è«ã«å¯ŸããŠãå¹æãããããããããªãç¹æ®ãšç æ°ã®æ¡æ£ãé²ãããšãã§ããŸãã
ããã«ãã€ãã«ã¡ã¯ããŒã«ã¯COVID-19æ²»çãžã®å¿çšå¯èœæ§ã«ã€ããŠãç 究ãé²ããããŠããŸãããã®è¬ã®æãŠã€ã«ã¹èœåããææè ã®ãŠã€ã«ã¹éãæžå°ãããå ç«ã·ã¹ãã ã調æŽããŠãŠã€ã«ã¹ãšããå¹æçã«æŠãããšã瀺åãããŠããããã§ããããããCOVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ããŒã«ã«å¯ŸããæåŸ ã¯æ éã§ããå¿ èŠããããŸãããã®å®å šæ§ãšå¹æã確ç«ããããã«ã¯ãå æ¬çãªèšåºè©Šéšãšç§åŠç 究ãäžå¯æ¬ ã§ããå»çå°é家ã¯ãCOVID-19ã®æèã§ã€ãã«ã¡ã¯ãã³ã䜿çšããå Žåã¯ãæ£è ã®å®å šãšå¥åº·ã確ä¿ããããã«ç¢ºç«ãããå»çã¬ã€ãã©ã€ã³ã«å³æ Œã«åŸãã¹ãã ãšå©èšããŠããŸãã
ã€ãã«ã¡ã¯ããŒã«
Ůᅵãã€ãã«ã¡ã¯ããŒã« 12 mg ãã¶
ãã®ãããªæåã¯ãçµç¹ããçŽæ¥ããŸãã¯èžç®¡ããã®ãªã³ããçµç±ããŠè¡æ¶²ã«å°éããå¯èœæ§ããããŸã å®ã 12 mg ã€ãã«ã¡ã¯ããŒã«ã 现èæ§å ç«å¿çã§ã¯ããã¯ããã¡ãŒãžã貪é£ãã埮çç©ã®æåããšãã§ã¯ã¿ãŒ T 现èã«æ瀺ãããšãã§ã¯ã¿ãŒ T 现èã¯ãã¯ããã¡ãŒãžã掻æ§åããŠæåãã埮çç©ã殺ããŸãã 埪ç°ããåçã¯ãææãççã®ããããéšäœã«ç§»åããããšãã§ããããã§ãã¯ããã¡ãŒãžã«ååããç Žå£ã®å段éãšããŠåŸ®çç©ã貪é£ããŸãã äœæ¶²æ§å ç«å¿çã§ã¯ãB ãªã³ãçãã¿ã³ãã¯è³ªæåãå éšåãããããã®ã¿ã³ãã¯è³ªãã掟çããããããããã«ã㌠T 现èã«æ瀺ããŸãã B 现èã®ãã®æåæ瀺æ©èœã¯ããã«ã㌠T 现èäŸåæ§ã®æäœç£çã«äžå¯æ¬ ã§ã (第 12 ç« ãåç §)ã ãã¹ãŠã®æ žçŽ°èã¯ã-MACROS- ãŠã€ã«ã¹ææããã³çãåŒãèµ·ããçªç¶å€ç° ã®åœ±é¿ãåããããã§ãã ãããã£ãŠãå ç«ç³»ããããã现èã¿ã€ãã«ãããŠããŠã€ã«ã¹æåãå€ç°ã¿ã³ãã¯è³ªãªã©ã®çŽ°è質æåãèªèã§ããããšãéèŠã§ãã è¡ç®¡å ç®çŽ°èã¯ãè¡ç®¡å£ã«ä»çããè¡æ¶²T现èã«æåãæ瀺ããå¯èœæ§ãããããã®ããã»ã¹ã¯ã现èæ§å ç«åå¿ã«ããããšãã§ã¯ã¿ãŒT现èã®åå¡ãšæŽ»æ§åã«å¯äžããå¯èœæ§ããããŸãã 移æ€çå ã®å ç®çŽ°èãã移æ€çæåã«åå¿ãã T 现èã®æšçãšãªããŸã (第 17 ç« ãåç §)ã ãããã®çŽ°èéå£ã«ããæåæ瀺ã®ççåŠçæ矩ã¯äžæã§ãã 1940 幎代ã«ã¯ã移æ€çæ絶åå¿ã®éºäŒçæ ¹æ ãåæããããã«ãç 究è ãã¯å åŒå士ã®äº€é ãç¹°ãè¿ããŠè¿èŠªäº€é ããããŠã¹ã®ç³»çµ±ãäœãåºããŸããã ç°ãªãæ ªã¯ç°ãªã察ç«éºäŒåãçºçŸããå¯èœæ§ããããäºãã«åçš®ç°ç³»ã§ãããšèšãããŠããŸãã ä»ã®ç³»çµ±ããã®ç§»æ€çãæ絶ããããä»ã®ãã¹ãŠã®éºäŒå ãåäžã§ããåç³»ããŠã¹ãç¹æ®ãããããšã«ãããç 究è ãã¯ãæè²äœ 17 äžã®åäžã®éºäŒåé åãçµç¹ç§»æ€çã®æ¥éãªæ絶 ã®äž»ãªåå ã§ããããšã瀺ãããã®é åã¯äž»èŠçµç¹é©åéºäŒå座 (çµç¹ãçµç¹) ãšåŒã°ããŸããã åœåããã®éºäŒå座ã«ã¯ãçµç¹é©åæ§ãå¶åŸ¡ããåäžã®éºäŒåãå«ãŸããŠãããšèããããŠããŸããã ããããç°ãªãæ ªã®äº€é äžã« H-2 éºäŒå座å ã§ææçµã¿æãã€ãã³ããçºçããŸãããããã¯ãå®éã«ã¯ããã€ãã®ç°ãªããå¯æ¥ã«é¢é£ããéºäŒåãå«ãŸããŠããããšã瀺ããŠããŸãããã®å€ãã¯ç§»æ€çæ絶åå¿ã«é¢äžããŠããŸããã 移æ€çæ絶åå¿ãå¶åŸ¡ããè€æ°ã®é£ééºäŒåãå«ãéºäŒåé åã¯ãäž»èŠçµç¹é©åéºäŒåè€åäœ-MACROS-ãšåä»ããããŸããã ãã®äœæ¥ã¯ãè€æ°åã®èŒžè¡ãåããå人ãè è移æ€ãåããæ£è ããè¡æ¶²ãŸãã¯è èã®æäŸè ããã®çŽ°èãèªèããæäœ-MACROS-ãæã£ãŠããããšããŸãçµç£å©Šãç¶èŠªã®çŽ°èãèªèããæäœ-MACROS-ã埪ç°ããŠããããšãçºèŠãããããšã§å®çŸå¯èœã«ãªããŸããã 移æ€çæ絶åå¿ã«ããã»ã©å¯äžããªããã®ä»ã®å€åéºäŒåã¯ããã€ããŒçµç¹é©åæ§éºäŒåãšåŒã°ããŸãããããã«ã€ããŠã¯ã移æ€å ç«åŠã«ã€ããŠèª¬æãã第 17 ç« ã§å床åãäžããŸãã ããã¯å ç«åŠè ã«ãšã£ãŠè¬ã§ããããªããªãã移æ€ã¯èªç¶çŸè±¡ã§ã¯ãªããããéºäŒåã®å¯äžã®æ©èœãç°ç©çµç¹ç§»æ€ã®æ絶åå¿ãå¶åŸ¡ããããšã§ãããªãã°ãéºäŒåã»ãããé²åãéããŠä¿åãããçç±ã¯ãªãããã§ãã å ç«åŠè ã¯ãåäžçš®ïŒã¢ã«ã¢ãããŸãã¯ããŠã¹ïŒã®è¿èŠªäº€é çš®ããããã€ãã®åçŽãªåæããªããããã«å¯Ÿããæäœãäœãèœåãç°ãªãããã®åå¿æ§ãåªæ§ã¡ã³ãã«éºäŒåœ¢è³ªãšããŠéºäŒããããšãçºèŠããŸããã å€åæ§ãšã¯ãç°ç³»äº€é éå£å ã®åäœéã§ã®éºäŒåã®å€ç°ãæããŸãã ããããéå£å ã«ããã»ã©èšå€§ãªæ°ã®å¯Ÿç«éºäŒåãä¿åããŠããéžæå§ã¯ç解ãããŠããªã -ãã¯ã-ã Kk ããã³ Dk 察ç«éºäŒåãæã€è¿äº€ç³»ããŠã¹ã«èŠããã IA 察ç«éºäŒåã¯ãI-Ak (IA of k ãšçºé³) ãšåŒã°ããŸãã ããã¯ãèªç¶å ç«ãç²åŸå ç«å¿çãåºæ¿ããã¡ã«ããºã ã® 1 ã€ã§ãã æåã®åŠçãšæ瀺ã«é¢äžããå€ãã®ã¿ã³ãã¯è³ªã®çºçŸã¯å調çã«å¶åŸ¡ãããŠããŸãã éããªããããã®çŽ 4 åã® 3 ã¯çŽ°èå€ã«ãããçãçæ°Žæ§ã»ã°ã¡ã³ãã现èèã«ãŸããããã«ã«ããã·æ«ç«¯æ®åºã¯çŽ°è質 ã«äœçœ®ããŸãã é ã®ã¢ããæ«ç«¯ 1 ããã³ 2 ã»ã°ã¡ã³ãã¯ãããããçŽ 90 æ®åºã®é·ã ã§ãããçžäºäœçšããŠã2 æ¬ã®å¹³è¡ãªãããé ãæ¯ãã 8 æ¬ã®é ã®åå¹³è¡ãªããªãŒã ã·ãŒãã®ãã©ãããã©ãŒã ã圢æããŸãã ãã®ãµã€ãºã¯ã8 ïœ 11 åã®ã¢ããé žãããªããããããæè»ãªæ¡åŒµã³ã³ãã©ã¡ãŒã·ã§ã³ã® MACROS ã§çµåããã®ã«ååãªå€§ãã (çŽ 25 à à 10 à à 11 à ) ã§ãã ã¯ã©ã¹ I ããããçµåæºã®ç«¯ã¯éããããŠããããããã倧ããªãããããå容ããããšã¯ã§ããŸããã ã¯ã©ã¹ I ååã¯ãéå€åœ¢æ§ 2-ãã¯ãã°ãããªã³ (2m) ã«éå ±æçµåããå€åœ¢éã§æ§æãããŠããŸãã 3 ã»ã°ã¡ã³ãã® ãšåæ§ã«ã2microglobulin 㯠Ig ãã¡ã€ã³ã® ãšæ§é çã«çžåã§ããããã¹ãŠã®ã¯ã©ã¹ I åå éã§äžå€ã§ãã å®å šã«çµã¿ç«ãŠãããã¯ã©ã¹ I ååã¯ãéã2-ãã¯ãã°ãããªã³ãããã³çµåãããã ãããªãäžéäœè€åäœã§ããã现èè¡šé¢ã§ã®ã¯ã©ã¹ I ååã®å®å®ããçºçŸã«ã¯ãè€åäœ ã® 3 ã€ã®ã³ã³ããŒãã³ããã¹ãŠãååšããããšãå¿ èŠã§ãã ãã®çç±ã¯ãããããæåã1çªç®ãš2çªç®ã®ã»ã°ã¡ã³ã-MACROS-ã«ãã£ãŠåœ¢æãããæº-MACROS-ã«çµåããããšã«ãã£ãŠãéãš2-ãã¯ãã°ãããªã³ãšã®çžäºäœçšãå®å®åãããéã«-MACROS-ã§ã¯ã2-ãã¯ãã°ãããªã³ãšé-MACROS-ãšã®çžäºäœçšã«ãã£ãŠããããã®çµåã匷åãããããã§ããã è£ãç®ã®åºã® 4 æ¬ã®ã¹ãã©ã³ããšãããå£ã® 1 ã€ã¯ 1 ã€ã®ã»ã°ã¡ã³ã ã«ãã£ãŠåœ¢æãããåºã®æ®ãã® 4 æ¬ã®ã¹ãã©ã³ããš 2 çªç®ã®å£ã¯ 1 ã€ã®ã»ã°ã¡ã³ã ã«ãã£ãŠåœ¢æãããŸãã 2 ããã³ 2 ã»ã°ã¡ã³ãã®ã«ã«ããã·æ«ç«¯ã¯çãæ¥ç¶é åã«ç¶ãããã®åŸã«çæ°Žæ§è貫éæ®åº ã®çŽ 25 ã¢ããé žé åãç¶ããŸãã ã©ã¡ãã®é ã«ãããŠããè貫éé åã¯å¡©åºæ§ã¢ããé žæ®åºã®ã¯ã©ã¹ã¿ãŒ ã§çµããããã®åŸã«çã芪氎æ§çŽ°è質æ«ç«¯ ãç¶ããŸãã ãããã®ããã»ã¹ã®ã¡ã«ããºã ãšéèŠæ§ã«ã€ããŠã¯ããã®ç« ã®åŸåã®ããã¯ããã§èª¬æããŸãã ãããã®ããã»ã¹ã«ãããT 现èã¯æ£åžžã«èªå·±æåã«å¯ŸããŠå¯å®¹ã«ãªããŸã (第 15 ç« ãåç §)ã
Åï¿œåŒ 12 mg ã€ãã«ã¡ã¯ããŒã« é«éé é
ãã®åè網ã¯èµèã®é éšãšé€ç¶çªèµ·ãããã³åäºæè žã«è¡æ¶²ãäŸçµŠããŸã ãžã§ããªã㯠12 mg ã€ãã«ã¡ã¯ããŒã« OTCã å°è žåèãšåè žåè äžèµåäºæè žåèã®é äœéšã§ã¯ãäžè žéèåèãå€æ°ã®æãåå²ãããŠããŸãã å·ŠåŽã«ã¯å€æ°ã®å°è žåèãšåè žåèãçºçããå°è žãšåè žã®å€§éšåã«è¡æ¶²ãäŸçµŠããŠããŸãã ãããã®æã¯åèã®äž»å¹¹ããåºãŠãè žéèã® 2 ã€ã®å±€ã®éãééããå€åŽã«åºãŠå°è žã«äŸçµŠãããšãã«å»ååŒãŸãã¯ã¢ãŒã±ãŒãã圢æããŸãã å±æ解å · è ¹éšèåš 4 暪è¡çµè ž äžèµåäºæè žåè äžçµè žåè äžè žéèåè å°è ž å³çµè žåè äžè¡çµè ž åçµè žåè çµè žæ å°è žåè çŽç®¡ åç²è žåè åŸç²è žåè è«ååè è«å åè žåè åè žã ç©ºè žé å-MACROS-ã«ã¯åäžã®ã¢ãŒã±ãŒãã次ã«äºéã®ã¢ãŒã±ãŒããååšããå¯èœæ§ããããåè žé å-MACROS-ã«ç§»åããŠåè žé åãééããã¢ãŒã±ãŒãã®æ°ã¯ç¶ç¶çã«å¢å ããŸãã æ«ç«¯ã¢ãŒã±ãŒãããã¯çŽè žè¡ç®¡ïŒçã£çŽããªåèïŒã䌞ã³ãŠããããããå°è žã®å£ã«çŽæ¥çãªè¡ç®¡äŸçµŠãè¡ã£ãŠããŸãã å°è žã«è¡æ¶²ãäŸçµŠããçŽè¡ç®¡ã¯éåžžé·ããäºãã«æ¥è¿ããŠãããè žéèã«èŠããçãçªã圢æããŸãã åè žã«è¡æ¶²ãäŸçµŠããçŽè¡ç®¡ã¯ãäžè¬çã«çããé¢ããŠãããäœãåºãçª ã圢æããŸãã äžçµè žåèã¯ãäžè žéèåèïŒãã¯ãã¹ïŒã®äž»å¹¹ã®å³åŽããåºã 3 ã€ã®æã®ãã¡ã®æåã®ãã®ã§ãã äžè žéèåèãèµèã®äžããåºãŠãããšïŒãã¯ãã¹ïŒãäžçµè žåèã暪è¡çµè žéèã«å ¥ããå³æãšå·Šæã«åãããŸãïŒãã¯ãã¹ïŒã å³æã¯å³çµè žåèãšå»åããå·Šæã¯äžè žéèåè ã®æã§ããå·Šçµè žåè ãšå»åããŸãã å³çµè žåè äžè žéèåè䞻幹-MACROS-ã«æ²¿ã£ãŠé äœæ¹åã«ç¶ãå³çµè žåèã¯ãäžè žéèåè䞻幹-MACROS-ã®å³åŽãã 3 ã€ããæã®ãã¡ 2 çªç®ã§ãã ããã¯äžæŽåãªæ ã§ãããåŸè ¹èã®äœçœ®ã§å³ ã«æž¡ããäžè¡çµè ž ã«äŸçµŠããŸãã çµè ž ã«è¿ã¥ããšãåçµè žåè ãšå»åããäžè¡æ ãšãäžçµè žåè ãšå»åããäžè¡æ ã«åãããŸãã åçµè žåè äžè žéèåèã®å³åŽããçºçããæåŸã®æãåçµè žåè ã§ãã ããã¯äžæ¹ã«é²ã¿ãå³è žéªšçª©ã«åãã£ãŠå³ã«é²ã¿ãããã§äžæãšäžæã«åãããŸããäžæã¯äžè¡çµè žã«æ²¿ã£ãŠäžæ¹ã«é²ã¿ãå³çµè žåèãšå»åããŸãã äžéšæã¯åçµè žæ¥åéšã«åãã£ãŠç¶ããçµè žæãç²è žæãè«åæãåè žæ ã«åãããŸãã ãããã®æã®ååžãšèµ·æºã®å ·äœçãªãã¿ãŒã³ã¯ããŸããŸã§ããçµè žæã¯äžè¡çµè žã暪åããäžæ¹ã«é²ãã§äžè¡çµè žã®æåã®éšåã«äŸçµŠããŸãã åç²è žæãšåŸç²è žæ ã¯ãå ±éã®å¹¹ãšããŠããŸãã¯å¥ã ã®æ ãšããŠçºçããç²è ž ã®å¯Ÿå¿ããåŽé¢ã«è¡æ¶²ãäŸçµŠããŸãã è«åæã¯èªç±çžã«å ¥ããäžè«åãšè«åã«æ é€ãäžããŸãã åè žæã¯å·Šã«é²ã¿ãåè žã®æ«æ¢¢éšã«äŸçµŠãããŸã§äžæãããã®åŸäžè žéèåèãšå»åããŸãã äžè žéèåèã¯ãåŸè žã«è¡æ¶²ãäŸçµŠããè ¹éšå€§åèã®åæã§ãã äžè žéèåèã¯ãæåã«åæ¹ã«äžéããŠå€§åèã«éãã次ã«å·Šã«é²ã¿ãªããäžæ¹ã«é²ã¿ç¶ããŸãã ãã®æã«ã¯ãå·Šçµè žåèãããã€ãã® S ç¶åèãããã³äžçŽè žåè ãå«ãŸããŸãã å·Šçµè žåèã¯äžè žéèåèïŒãã¯ãã¹ïŒã®æåã®æã§ãã ããã¯åŸè ¹èã«æ²¿ã£ãŠäžæããäžè¡æãšäžè¡æã«åãããŸããäžè¡æã¯å·Šè èã®åæ¹ãééãã暪è¡çµè žéèã«å ¥ããäžæ¹ã«ééããŠäžè¡çµè žã®äžéšãšæšªè¡çµè žã®é äœéšã«äŸçµŠããäžçµè žåèã®æãšå»åããŸãã äžè¡æã¯äžæ¹ã«ééã-MACROS-ãäžè¡çµè žã®äžéšã«è¡æ¶²ãäŸçµŠãã第 1 S ç¶åè-MACROS-ãšå»åããŸãã Sç¶åè Sç¶åèã¯2ïœ4æ¬ã®æããæ§æãããSç¶çµè žäžèã®å·ŠåŽãŸã§äžéããäžè¡çµè žã®æäžéšãšSç¶çµè žã«è¡æ¶²ãäŸçµŠããŸãã ãããã®æã¯ãäžæ¹ã§ã¯å·Šçµè žåèããã®æãšå»åããäžæ¹ã§ã¯äžçŽè žåè ããã®æãšå»åããŸãã äžçŽè žåèã¯äžè žéèåèã®æ«ç«¯æã§ãããäžçŽè žåè ãšåŒã°ããŸãã ãã®è¡ç®¡ã¯ãå·Šç·è žéªšè¡ç®¡ ã暪åããSç¶çµè žéè ãéã£ãŠéªšç€è ã«äžéããŸãã 2 ã€ã®æ«ç«¯æã¯çŽè žã®äž¡åŽã«äžéããçŽè žã®å£ã§ããã«å°ããªæã«åå²ããŸãã ãããã®å°ããªæã¯ãå èéæ¬çŽçã®ã¬ãã«ãŸã§äžæ¹ã«ç¶ããéäžã§äžçŽè žåèïŒå è žéªšåèããïŒããã³äžçŽè žåèïŒå é°éšåèããïŒããã®æãšå»åããŸãã èšåºã¢ããªã±ãŒã·ã§ã³ æ¶ååšç³»ãžã®è¡ç®¡äŸçµŠ åè硬åã¯ãè ¹éšå€§åèå šäœãããã³è ¹è åèã®éå£éšãäžè žéèåèãšäžè žéèåèã®éå£éšã§çºçããå¯èœæ§ããããŸãã èå³æ·±ãããšã«ããããã®æ£è ã®å€ãã¯ãå³çµè žåèãäžçµè žåèãå·Šçµè žåèéã®å»åãåŸã ã«æ¡å€§ããé£ç¶ãã蟺çžåèã圢æãããããå䜵çãèµ·ãããŸããã ãããã£ãŠãé äœå€§è žã¯ããã®æ¡å€§ãã蟺çžåèïŒãã©ã¢ã³ã蟺çžåèïŒ-MACROS-ã«ãã£ãŠè¡æ¶²äŸçµŠãåããããã«ãªããäžè žéèåè-MACROS-ã®è¡æ¶²äŸçµŠã«åã£ãŠä»£ãããŸãã 暪è¡çµè ž äžè¡çµè ž éèãã¬ããŒãž èŸèãèµèãèå¢ãããã³çŽè žã®äžéšãé€ãæ¶å管ã®è ¹éšã®éèãã¬ããŒãžã¯ãéèç³»éèãä»ããŠè¡ãããéèç³»ã¯ãããã®æ§é ããèèã«è¡æ¶²ãéããŸãã è¡æ¶²ãèé¡æŽãééãããšã次第ã«å€ªãéèãééããŠèéèã«å ¥ããéèè¡ã¯æšªéèã®ããäžã«ããäžå€§éèã«æ»ããŸãã éèã¯ãèŸèãèµèãèå¢ãããã³æ¶å管ã®è ¹éšããã®éèè¡ã茞éããããã®æåŸã®å ±éçµè·¯ã§ãã éèã¯èèã«åãã£ãŠäžæããåäºæè žã®äžéšã®åŸæ¹ãééããŠå°ç¶²ã®å³çžã«å ¥ããŸãã å°ç¶²ã®ãã®éšåãééããéã倧網åã®åæ¹ã«ãããè管ã®å³åŽã«ãããã«é¢ããŠããè管ãšãèåèã®å·ŠåŽã«ãããã«é¢ããŠããèåèã®åŸæ¹ã«ãããŸãã
Ãï¿œãã«ã¡ã¯ããŒã« 12 mg ãžã§ããªãã¯ããªã³ã©ã€ã³ã§è³Œå ¥
åŒãè£ãã¯ãå ããããåã®æ¹åãšéã«å¿ããŠãçŽç·ç¶ããæç¶ã«ãªãããšããããŸãã è£å·ã¯ãéåžžãéãåãŸãã¯éãåã«ããäžèŠåãªç©äœãšã®æ¥è§Šã«ãã£ãŠçºçããç®èã®è¡šé¢ãç Žãã»ã©ã®åãå ãããšçºçããŸãã åéã«ã¯ãéå©ãªç©äœïŒãã®å Žåã¯ãã©ã®ãã²ïŒãã¯ãã¹ïŒïŒã«ãã£ãŠäœããããããããªïŒãã¯ãã¹ïŒçã£çŽããªãšããžããããŸãã çž«åã«ãããå€ç§æè¡ã«ããåéãªã©ã®åééšã®ç«¯ãè¿ã¥ããæ¹ããå·ãèªç¶ã«æ²»çããå·è·¡ãã»ãšãã©ãŸãã¯ãŸã£ããæ®ããªãããã«ããã®ã容æã«ãªããŸãã åºãå·ã®åœ¢ç¶ã¯ãåéã軞ã«æ²¿ã£ãŠããããã©ã³ã¬ãŒç·ã«åçŽã§ãããã«ãã£ãŠå€§ããç°ãªããŸãã åçŽã«åéãããšåŒãé¢ãããŠå£ãéãåŸåããããŸãããå¿åã®ãããç·ã«å¹³è¡ã«åéãããšã¹ãªããç¶ã®åœ¢ãæ®ãåŸåããããŸãã å³ããã«ã®åºãå·ã«ã¯ãéãåå ã€ãã«ã¡ã¯ããŒã« 12mg ã OTC ã§è³Œå ¥ ã®å察åŽã«ãæãã®è·¡ããããŸãã æããé»æµãæµãåºãéã«çããå·ã¯ãæã®ç²ã«èŠãããŸãã ããã«ç€ºãããŠããåäŸã®èŽäœãšé éšã®çŒããç®èã¯ãç«çœã«ãããã®ã§ãã å·å®³ãåŒãèµ·ããã®ã«çã¯å¿ èŠãããŸãããç±ã¯ç©ºæ°ã液äœãåºäœãä»ããŠäŒå°ããŸãã æ²»çãšäºåŸã¯ãç«å·ã®çšåºŠãã€ãŸã圱é¿ãåããäœè¡šé¢ç©-MACROS-ã«å€§ããå·Šå³ãããããšãå€ãã§ãã ãã®ä»ã®èŠå ãšããŠã¯ãæ£è ã®é«éœ¢ãåºç€çŸæ£ããããŠå»ºç©ãªã©ã®å¯éããã空éã§ã®ç«çœã§å žåçã«çºçããé«æž©ã¬ã¹ãåžã蟌ãããšã«ãããåžå ¥å·å®³ãã®ååšãªã©ãæããããŸãã 瀺ãããŠããæå·ã¯ãçç®å ã«çåå¯èœã§æ°ããäžç®ãæé·ããå¯èœæ§ã®ããåºåºçŽ°èãšä»å±åšæ§é ããããããå·ŠåŽã«éšåçãªåãããããŸãã å·ŠåŽã®çåå¯èœãªç®èã¯ãå³åŽã®è¡šé¢ã«ãçç®ä»å±åšã«ãçåå¯èœãªäžç®ããªããå šå±€ç±å·ã®é åãšèåããŠããŸãã æ£è ãå埩ããã«ã¯ããã®å šå±€ç«å·éšäœã«ç®è移æ€ãå¿ èŠã«ãªããŸãã ææ°ã®æªã家å±ãæ éããããŒã¿ãŒãäœå® ç«çœãèªåè»ã®ææ°ã¬ã¹ãªã©ãæãäžè¬çãªçºçæºã§ãã äžé žåççŽ ã¯é žçŽ ããã 200 åã匷ããã¢ã°ããã³ã«çµåããããã倧æ°äžã®äžé žåççŽ æ¿åºŠããããã§ãå±éºã§ãã 20% ïœ 30% ã®ã¬ãã«ã§ã¯ãå¿èãŸãã¯åŒåžåšçŸæ£ãæ£ã£ãŠãã人ã«ãšã£ãŠã¯èŽåœçãšãªãå¯èœæ§ããããŸãã åæ§ã®éé»ãã¯ãã·ã¢ã³åç©äžæ¯ãŸãã¯ã¢ããã«ãªãé ¢é žäžæ¯ã«ãã£ãŠãçããå¯èœæ§ããããŸãã é¡èãªã¡ã©ãã³çŽ°èå¢æ®ããã³è€è²è²çŽ æ²çã䌎ã網ç¶éèµ·ã®äŒžé·ã¯ãè人æ§é»å ãè¡šããæã«å¹³åŠãªè€è²ã®æç¹ãšããŠçŸããŸãã ããã¯ãè¬å€ãé£åãååŠç©è³ªãªã©ã®ã¢ã¬ã«ã²ã³ã«å¯ŸããIåéæçåå¿ã®äžçš®ã§ãã ãã®ãããªæå·ã¯ãååŠè£œåããã¯ãã¹ãã®ã©ãã«ã«ãç®èãšã®æ¥è§Šãé¿ããããšèšèŒãããŠããã«ããããããã泚æãæ ã£ãããã«çºçããå¯èœæ§ããããŸãã å粧åãªã©ã®è£œåã«ãã¢ã¬ã«ã®ãŒåå¿ãåŒãèµ·ããå¯èœæ§ã®ããç©è³ªãå«ãŸããŠããå ŽåããããŸã ã®ã§ããŸãã¯ç®èã®å°ããªéšåã«ãã¹ãçã«å¡ã£ãŠãã ãã ã å±æã³ã«ãã³ã¹ããã€ãã¯ãççã軜æžãã1ïœ2 é±éãããŠçç¶ãæ²»ãŸããŸã§åŸ ã€ã®ã«åœ¹ç«ã€å¯èœæ§ããããŸãã ãã®æ¹¿ç¹åå¿ã¯ãæ°Žç±æ§äžç¹-MACROS-ã滲åºæ§çºç¹-MACROS-ãããã³çç®æ§ç å€-MACROS-ãç¹åŸŽãšããŸãã ãã®ççåå¿ã¯ãæ»çã䌎ããªãç°ç¶ã®çŽ æãšããŠçŸããäžå¿ã§ã¯æ¶å€±ããªããæ«æ¢¢ã«åºãããŸãã è¥æºçŽ°èçŸæ£æ£è ã®çŽ 10% ã¯å šèº«æ§çŸæ£ ãæ£ã£ãŠãããè¥æºçŽ°èãå€ãã®èåšã«æµžæœ€ããŠããŸãã å šèº«æ§è¥æºçŽ°èçã¯ãç¹å®ã®é£åã®æåã枩床å€åãã¢ã«ã³ãŒã«ãè¬ç©ã®æåã«ãã£ãŠåŒãèµ·ãããããããçãé¡é¢çŽ 朮ãªã©ã®è¥æºçŽ°èã®è±é¡ç²ã®åœ±é¿ãåããããšããããŸãã 骚ãžã®æµžæœ€ã¯ãè «ç€å¹æã«ããçã¿ããéå°ãªãã¹ã¿ãã³æŸåºã®åœ±é¿ã«ããç ç骚æãåŒãèµ·ããã骚ç²é¬çãåŒãèµ·ããå¯èœæ§ããããŸãã çç®ã®ããæ·±ããŸã§æµžæœ€ããç å€ã¯è»¢ç§»ã®å¯èœæ§ãé«ããªãã転移ã¯æåã«å±æãªã³ãç¯ã«çŸããå¯èœæ§ããããŸãã é»åé¡åŸ®é¡æ€æ»ã§ã¯ããã¬ã¡ã©ããœãŒã ã瀺ãããã°ãè «çãé»è²è «ã§ããããšã蚌æã§ããå¯èœæ§ããããŸãã ããã§ã¯ããã¬ã¡ã©ããœãŒã ã® 2 ã€ã®äŸããããããªçžæš¡æ§ ã®ããæ¥å圢ã®æ§é ãšããŠèŠããŠããããããã¥ã¢ã®ã¹ããŒã·ã¥ãŒ ã®ããã«èŠããŸãã ããã¯éåžžãæå€§åŸ 2 cm æªæºã®ããŒã åç å€ãšããŠé«éœ¢è ã®çœäººã«èŠãããŸãã å±æãªã³ãç¯ãžã®è»¢ç§»ã¯é »ç¹ã«çºçããæ£è ã®åæ°æªæºã 2 幎以äžçåããŸãã æ人ã®åè¢ã®ç®èã«ã倧ãããæ°ããªã¡ãŒãã«ã®å°ããªçµç¯ãåç¬ã§ããŸãã¯è€æ°åçºçããããšããããŸãã ãŸãã« 1 cm ãè¶ ããŠæé·ããæéã®çµéãšãšãã«ãµã€ãºã倧ãããªã£ããå°ãããªã£ããããããšããããŸãããæ¥éã«æé·ããããšã¯ãŸãã§ããã䟵襲æ§ã¯ãããŸããã è§è³ªå¢æ®çãè²çŽ æ²çéå°ãéãªããèµ€è€è²ã«ãªãå ŽåããããŸãã å Žåã«ãã£ãŠã¯ã以åã«å€å·ã®å±¥æŽãããããã®ç å€ããã±ãã€ãã«äŒŒãŠãããããå±æçãªãå€å·ã«å¯Ÿããç°åžžã ãå±æçãªåå¿ã§ããããšã瀺åããŠããŸãã äžã«ããè¡šç®ã¯ãããã§ç€ºãããã«ãåœäžç®è «æ§é圢æ ãšåŒã°ããã網ç¶éèµ·ãäžæ¹ã«äŒžé·ãã é圢æ ã䌎ãããšãå€ã ã å¯Ÿç §çã«ãæªæ§ç·ç¶æ§çµç¹çè «ã¯ãè»éšçµç¹ã«çºçããèè «ã®äžçš®ã§ãããéåžžã«æ»æçã«äœçšããŸãã ãããã®ç å€ã¯ãã£ãããšæé·ããããšãå€ããäžè¬çã«ã¯ç®èè¡šé¢ã®äžã®åãªãåä»ãªãéèµ·ãã§ã -ãã¯ã-ã
Ãï¿œãã«ã¡ã¯ããŒã« 12mg è³Œå ¥ã©ã€ã³
ãåç¥ã§ãã? ä¹³å ã幌å ã¯èãæ¯èŒç倧ãããåé ãããé åŽã«ãããããçŽæ¥åé é¡æ€æ»äžã«åé ãé²åºãããããã«å£è 軞ãåœé 軞ãããã³æ°ç®¡è»žãäžçŽç·ã«äžŠã¹ãå¿ èŠãããè·é¢ãå®è³ªçã«çããªããŸãã å°å æ£è ã®å°é£ãªæ°é管çã«ã¯ãæ·±ãé®éãŸãã¯å šèº«éº»é ãå¿ èŠã«ãªãããšããããããŸã ã€ãã«ã¡ã¯ããŒã« 12 mg ãžã§ããªã㯠ãªã³ã©ã€ã³ã åé é¡æ€æ»ããã³æ°ç®¡å æ¿ç®¡ã®éº»é æ¡ä»¶ åŸæ¥ãå°å ã®æ°ç®¡æ¿ç®¡ã¯ã麻é ã®å°å ¥ãšéè±å極æ§ç¥çµçé®æè¬-MACROS-ã®æäžåŸã«è¡ãããŸãã ç¥çµçé®æè¬ã䜿çšããã«æ·±ã麻é äžã§åé é¡æ€æ»ãæ°ç®¡å æ¿ç®¡ãè¡ãããšãäžè¬çã«ãªã£ãŠããŸãã ããã¯ãã»ããã«ã©ã³ã®æ·±ã麻é ã®ã¿ã§è¡ãããšãã§ããŸã ããããããã©ãŒã«ããŒã©ã¹ã䜿çšããŠå®è¡ãããããšããããããŸã ã ç¥çµçé®æãªãã§éº»é 深床ãäžååãªå Žåãå³åœ-MACROS-ãåé çæ£-MACROS-ãé žçŽ ãã¢ã°ããã³è±é£œå床-MACROS-ãéæµ-MACROS-ãçããå¯èœæ§ããããŸãã é£åå»è¬åå±ã¯ããµã¯ã·ãã«ã³ãªã³ã«å¯ŸããŠãæ¥åžžçãªæ°é管ç ã§ã®äœ¿çšãçŠå¿ãšããé»æ èŠåãé©çšããŸããã ãã ããã¹ã¯ã·ãã«ã³ãªã³ã«å¯Ÿãã絶察ççŠå¿ïŒæªæ§é«ç±çæåæ§ãç«å·ã®æ¢åŸæŽãªã©ïŒããªãå Žåã¯é€ããŸãã åŸæ¥ãå°å ã®åé é¡æ€æ»ã«ã¯ã¹ãã¬ãŒããã¬ãŒãïŒãã©ãŒïŒã䜿çšãããŠããŸãããããã®ãã¬ãŒãã湟æ²ãã¬ãŒãïŒãããã³ããã·ã¥ïŒãããåªããŠããããšã瀺ãæ¯èŒèšŒæ ã¯ã»ãšãã©ããŸãã¯å šããããŸããïŒç¬¬ 20 ç« ãã¹ãã¬ãŒããã¬ãŒãããåç §ïŒã èãæããåŸïŒãã¯ãã¹ïŒãåå ãåé èè°·ãè¶ããŠé²ããåé èãçŽæ¥æã¡äžããŸãïŒãã¯ãã¹ïŒã ãããã¯ã-MACROS- ã§ã¯ããããã³ããã·ã¥ã®ããã«ã¹ãã¬ãŒããã¬ãŒãã䜿çšãããã¬ãŒãã®å 端ãåé èè°·ã«å ¥ããŠéæ¥çã«åé èãæã¡äžããããšãã§ããŸãã åé ãã¹ã¯ãšå£°éäžæ°é åé ãã¹ã¯æ°éã¯å°å 麻é ã§é »ç¹ã«äœ¿çšãããŸãã èæåºãã£ãã«ãåããåé ãã¹ã¯ãšãæ¿ç®¡ã容æã«ããããã«èšèšãããåé ãã¹ã¯ã¯ãå°å çšãµã€ãºã§å ¥æã§ããŸãã æ°ç®¡å ãã¥ãŒãã®éžæ æŽå²çã«ã¯ãå°å ã«ã¯ã«ããªãã®æ°ç®¡å ãã¥ãŒããæšå¥šãããŠããŸããããçŸä»£ã§ã¯ãã»ãšãã©ã®å Žåãã«ãä»ããã¥ãŒãã®æ¹ãåªããŠããŸãã é©åãªãµã€ãºã®ã«ãä»ããã¥ãŒãã䜿çšãããšãæ¿ç®¡åŸã®å鳎ã®çºççãäœããªããŸããããã¯ãæåã«æ¿å ¥ããããã¥ãŒããå°ããããå Žåã«ããã¥ãŒã亀æã®ããã«åé é¡æ€æ»ãç¹°ãè¿ãå¿ èŠæ§ãé »åºŠãæžããããšèããããŸãã ã«ãä»ãæ°ç®¡å ãã¥ãŒãã«ã¯ãæ°ç®¡ã®å¯éæ§ãåäžãããšããå©ç¹ããããŸããããã«ãããæè¡å®€ã®æ±æãæžå°ããæ°é®®ãªã¬ã¹ã®æµéãå°ãªããªãã人工åŒåžåšã®æ§èœãåäžããããã³ããã¯ã誀å¥ã«å¯Ÿããä¿è·ã匷åãããå¯èœæ§ããããŸãã æ°ç®¡æ¿ç®¡ãè¡ãå Žåã¯ãæ£ããæ°ç®¡ãã¥ãŒãã®ãµã€ãºãéžæããå¿ èŠããããŸãã æãäžè¬çã«ã¯ãä¿®æ£ãããã³ãŒã«ã®åŒãã«ããªãæ°ç®¡å ãã¥ãŒãã«äœ¿çšãããŸãããã®å Žåãäºæž¬ããããã¥ãŒãã®ãµã€ãºã¯ã4 ã«å¹Žéœ¢ã足ã㊠4 ã§å²ã£ãå€ã«ãªããŸãã ä¹³å ãå°ããå°å ã®å Žåãã«ãä»ããã¥ãŒãã䜿çšãããšãã¯ãããŒããµã€ãºå°ãããã®ãéžæããŠãã ããã æ°ç®¡æ¿ç®¡ãšæ°ç®¡å ãã¥ãŒãã®é 眮 å°å ã«ãããæ°ç®¡æ¿ç®¡ã®é©å¿ã¯ãæ人ã«ãããé©å¿ãšã»ãŒåæ§ã§ãã ããã«ãå€ãã®éº»é ç§å»ã¯ãä»ã®åŸæ¥ã®é©å¿ããªãå Žåã§ããæ°çå ãæªçå ã«æ°ç®¡æ¿ç®¡ãè¡ããææ°ãå¶åŸ¡ããŸãã æ°ç®¡ãã¥ãŒãã®å 端ãæ°ç®¡äžéšã«é 眮ããéã«ã¯çŽ°å¿ã®æ³šæãæãå¿ èŠããããŸãã ãã¥ãŒãã®å°ããªåãã«ãããä¹³å ã®æ°ç®¡æ¯æ¿ç®¡ãäžæ³šæã«ããæ管ã«ã€ãªããå¯èœæ§ããããŸãã æ°ç®¡å ãã¥ãŒãã®é©åãªæ·±ããè©äŸ¡ããã«ã¯ããã³ãããã°ææ°-MACROS-ã䜿çšããŠèŽèšºãšåŒåžãåæã«è¡ããªãããæ°ç®¡å ãã¥ãŒããäž»æ°ç®¡æ¯ãŸã§æå³çã«é²ããŸãã æ°ç®¡å ãã¥ãŒããå³ãŸãã¯å·Šã®äž»æ°ç®¡æ¯ã«å ¥ããšïŒãã¯ãã¹ïŒãããããå察åŽã®åŒåžé³ãèãããªããªããŸãïŒãã¯ãã¹ïŒã 次ã«ãä¹³å ã®å Žåã¯ãã¥ãŒãã 1 cmãæ°ç®¡åå²éšãã 2 cm åŒãæããåŒåžé³ã䜿çšããŠäž¡èºãææ°ãããŠããããšã確èªããŸãã ã«ãä»ããã¥ãŒãã䜿çšããå Žåãèžéªšäžåçå ã§ã®ãããã¡ã³ãã«ãã£ãŠã«ãã觊ç¥ã§ããããã«ãã¥ãŒããé 眮ããæ¹ãç°¡åãã€ä¿¡é Œæ§ãé«ããªãå ŽåããããŸãã ããã¯ããã¥ãŒãã®å 端ãèžè å ããã³æ°ç®¡ã®äžå€®ã®äœçœ®ã«ããããšãæå³ããŸãã ãåŸæ¥ã®ãæ¥éã·ãŒã±ã³ã¹èªå°ãå®è¡ããããšãã»ãŒãã¹ãŠã®ä¹³å 㧠1 åéã®ç¡åŒåžåŸã«é žçŽ ãã¢ã°ããã³é£œå床ã 90% æªæºã«ãªããŸãã ãã®ãããå€ãã®å°å 麻é ç§å»ã¯ããªã¹ã¯ãšãããã£ããã®èŠ³ç¹ãã誀å¥ãªã¹ã¯ãããé žçŽ äŸçµŠãåªå ãããããæ¿ç®¡åã«èŒªç¶è»éªšå§è¿«ã«å ããŠç©ãããªéœå§ææ°ã䌎ãä¿®æ£è¿ éå°å ¥æ³ãå®æœããŠããŸãïŒ9ïŒã äœæž©ç®¡ç 麻é äžã§ââã¯åäŸã¯äœäœæž©çã«ãªããªã¹ã¯ãé«ãŸããŸããç¹ã«ä¹³å ãç¹ã«æªçå ãšæ°çå ã¯æããªã¹ã¯ãé«ãã§ãã æŸå° èžçº å¯Ÿæµ äŒå° 麻é äžã®æ°çå ã¯å€æž©åç©ãšããŠè¡åãããã®äœæž©ã¯åšå²ã®æž©åºŠã«è¿ã¥ããŸãã åã ã®æ£è ã«åãããæŠç¥ãçµã¿åãããããšã§ãäœäœæž©ãäºé²ããæ£åžžäœæž©ãç¶æããããšãã§ããŸãã å©çšå¯èœãªæ¹æ³ãšããŠã¯ãæ£è å°çåã«æè¡å®€ãæããïŒå¯ŸæµãŸãã¯æŸå°ïŒ-MACROS-ã匷å¶ç©ºæ°å æž©ïŒå¯ŸæµïŒ-MACROS-ã埪ç°æž©æ°Žãããã¬ã¹ïŒäŒå°ïŒ-MACROS-ãå 湿ã¬ã¹ãŸãã¯å 湿氎å亀æåšïŒèžçºïŒ-MACROS-ãé äžã®èµ€å€ç·å æž©ç¯ïŒæŸå°ïŒãªã©ããããŸãã éèå 茞液ã®å¿ èŠé 絶é£äžã®å°å ã®éèå 茞液ã®å¿ èŠéã¯éåžžã4-2-1 ã«ãŒã« ã䜿çšããŠæ±ºå®ãããŸãã 1 æéãããã®æ³šå ¥é床ã¯ãæåã® 10 kg ã«å¯Ÿã㊠4 mL/kgã次㮠10 kg ã«å¯Ÿã㊠2 mL/kgãããã«è¿œå ã® 1 kg ããšã« 1 mL/kg ãšããŠèšç®ãããŸãã ç©ºè ¹æã®æ°Žåäžè¶³ã¯ããã®åŒãšåäŸãçµå£æåããŠããªãæéã«åºã¥ããŠèšç®ãããŸãã äžè¬çã«åãå ¥ããããŠããã¬ã€ãã©ã€ã³ã¯ãæåã® 1 æéã§äžè¶³åã® 50% ãè£å ãã次㫠2 æéç®ã«äžè¶³åã® 25% ãè£å ãã3 æéç®ã«äžè¶³åå šäœãè£å ããããšã§ãã çåŸ 6 ãææªæºã®ä¹³å ãç¹ã«æ°çå ã¯ã麻é 蚺çã§äžè¬çã«èŠããã絶é£æéã«äŒŽãäœè¡ç³ã®ãªã¹ã¯ãé«ããªããŸãã ãåç¥ã§ãã? åºè¡ã䌎ãè¡æ¶²éæžå°ã¯ãå°å ã®åšè¡æå¿åæ¢ã®æãäžè¬çãªå¿è¡ç®¡ç³»ã®åå ã§ãã 倱è¡è£å ããã³èŒžè¡ 倱è¡éã®éå°è©äŸ¡ãäžååãªæºåïŒè¡ç®¡ã¢ã¯ã»ã¹ãè¡æ¶²æºåïŒãããã³å€§éåºè¡ããå°å æ£è ïŒ1012ïŒã®å¿åæ¢ã®äžå ãšããŠç¹å®ãããŠããŸãã 茞è¡éŸå€ã¯æçµçã«ã¯åã ã®æ£è ãšèšåºã·ããªãªã«åãããŠèª¿æŽãããŸãããã»ãšãã©ã®ã·ããªãªã§ã¯ããã¢ã°ããã³ã 7 g/dL æªæºã®å Žåã«èµ€è¡ç茞è¡ãé©å¿ãšãªã (13,14)ãæ£è ã®å¹Žéœ¢ãšèšåºã·ããªãªã«ãã£ãŠã¯ããããæ©ãé©å¿ãšãªãããšããããããŸã (10,11)ã
Ãï¿œãã«ã¡ã¯ããŒã« 12 mg ãªã³ã©ã€ã³ æ Œå®è³Œå ¥
å è茞åºè·¯ïŒè¿·èµ°ç¥çµã¯çŽ°æ°ç®¡æ¯ãåçž®ããã亀æç¥çµç³»ã¯çŽ°æ°ç®¡æ¯ãæ¡åŒµããã ã€ãã«ã¡ã¯ããŒã« 12 mg æ Œå®ãã¹ã¿ãŒã«ãŒãã ãããã¯èºå ã§èºåèãšèºéèã®æãšçžäºæ¥ç¶ããŸã -ãã¯ã-ã æ°ç®¡æ¯åèã¯ãèžéšå€§åèãŸãã¯ãã®æã® 1 ã€ããå§ãŸããŸãã1 æ¬ã®å³æ°ç®¡æ¯åèã¯éåžžã第 3 åŸèéåèããå§ãŸã (ãã ãããŸãã«å·Šäžæ°ç®¡æ¯åèããå§ãŸãå ŽåããããŸã)ã-MACROS- ãŸãã æ°ç®¡æ¯åèã¯æ°ç®¡æ¯ã®åŸé¢ãèµ°ããèºã§åå²ããŠèºçµç¹ã«è¡æ¶²ãäŸçµŠããŸãã æ°ç®¡æ¯éèã¯ãèºéèãŸãã¯å·Šå¿æ¿ã«æµã蟌ã¿ãå³åŽã§ã¯å¥éèãå·ŠåŽã§ã¯äžèééèãŸãã¯åå¥éèã«æµã蟌ã¿ãŸãã ãªã³ããã¬ããŒãž èºã®è¡šå±€ãªã³ã管ããŸãã¯èžèäžãªã³ã管ãããã³æ·±éšãªã³ã管ã¯ãæ°ç®¡æ¯ãšäž»æ°ç®¡æ¯ã®æ ¹å ã®åšå²ãšæ°ç®¡ã®åŽé¢ã«ããæ°ç®¡æ°ç®¡æ¯ãªã³ãç¯ãšåŒã°ãããªã³ãç¯ã«æåºãããŸãã ãããã®ãªã³ãç¯ã¯ãã°ã«ãŒã ãšããŠãèºã®å éš ããèºéãšæ ¹éš ãéããåŸçžŠé ãŸã§åºãããŸãã å³æ°ç®¡æ¯äžé èžç®¡æ¬ç®¡ å³åè ¹å£ãªã³ã管 è é ãªã³ãç¯ å·Šæ°ç®¡æ¯äžéæ¬ç®¡ å·Šåè ¹å£ãªã³ã管 åè ¹å£ãªã³ãç¯ é žéšå¿èç¥çµ æ°ç®¡æ°ç®¡æ¯ãªã³ãç¯ å·Šååç¥çµ å³è ç¥çµ åèºå¢ å·Šè ç¥çµ åèé垯 åèºå¢ èžç®¡ 亀æç¥çµæ¬ç®¡ 暪éè ä¹³ã³è žç®¡ åœé ç¥çµå¢ã ãããã®ãªã³ãå¹¹ã¯ãéŠã®ä»ãæ ¹ã®æ·±éšéèã«çŽæ¥æåºããããïŒãã¯ãã¹ïŒãå³ãªã³ãå¹¹ãŸãã¯èžç®¡ã«æåºãããããšããããŸãïŒãã¯ãã¹ïŒã ç»åã¢ã㪠èºãèŠèŠå èºã¯äœå ã§æãç æ°ãçºçããããéšäœã® 1 ã€ã§ãããããèºã®å»ççšç»å蚺æã¯éèŠã§ãã äœãäŒãã§ããéãèºã¯ 1 åéã«æ倧 5 L ã®ç©ºæ°ã亀æããŸãããã®ç©ºæ°ã«ã¯ç åäœããã®ä»ã®æœåšçã«æ害ãªèŠçŽ ãå«ãŸããŠããå¯èœæ§ããããŸãã ãããã®ã¹ãã£ã³ã«ãããå»åž«ãæŸå°ç·ç§å»ã¯ç æ°ã®ãã¿ãŒã³ãšãã®ååžããã¯ãã§ç¢ºèªããããšãã§ããŸãã ãã®æé ã䜿çšããŠç°¡åã«æ€åºã§ããçŸæ£ã«ã¯ãèºæ°è «-MACROS-ã塵èºçïŒçé±åŽåè 塵èºçïŒ-MACROS-ãããã³ç³ç¶¿èº-MACROS-ãªã©ããããŸãã æ°ç®¡æ¯é¡ã¯éŒ»ããåœé ãŸã§éãããå¶åŸ¡æ°ç®¡åå²éšã«ãã£ãŠå³äž»æ°ç®¡æ¯ãå³äž»æ°ç®¡æ¯ Aãå·Šäž»æ°ç®¡æ¯ B ã®æ¹åã«å°ãããè «ç ã«é²ã¿ãŸãã å³èºã§ã¯äžèãäžèãäžè ã瀺ãããå·Šèºã§ã¯äžèãšäžè ã瀺ãããŠããŸãã å³èºã¯äžèãšäžèã瀺ããå·Šèºã¯äžèãšäžèã瀺ããŠããŸãã æ°ç®¡ãé骚ãè骚ãäžå€§éèã倧åèåŒãèºåèå¹¹ãå³å¿æ¿ãå·Šå¿å®€ã暪éèã®å³ããŒã ã暪éèã®å·ŠããŒã ã暪éèé¥å¹ -ãã¯ã-ã èºã®äžã«å°ããªæªæ§çµç¯ãèŠã€ãã£ãå Žåãåé€ã§ããå ŽåããããäºåŸã¯è¯å¥œã§ãã æ®å¿µãªããšã«ãå€ãã®æ£è ã¯ã瞊éãŸãã¯èžèã®æ§é ã«äŸµå ¥ããããŸãã¯è»¢ç§»ããè «çå¡ãåããŸãã ãã®å Žåãè «çã¯æè¡äžèœãšãªãå¯èœæ§ããããæŸå°ç·çæ³ãšååŠçæ³ïŒãã¯ãã¹ïŒã§æ²»çãããŸãã è «çã¯ãªã³ã管ãéã£ãŠãèºéã瞊éãé žéšæ ¹éšã«ãããªã³ãç¯ã«åºãããŸãã ææãç¶ç¶ãããšã滲åºæ¶²ãšæŒåºæ¶²ãçæãããèºèãšäºæ¬¡èºå°èãæºããããŸãã ãã®ã¿ã€ãã®ææçã®æ¡æ£æ§ãæç¶ã®æ§è³ªã¯ãæ°ç®¡æ¯èºçãšåŒã°ããŸãã 瞊éã¯ã暪æ¹åã«é 眮ããã 2 ã€ã®èžèè ãåããåºãäžå€®ã®ä»åãã§ãã ããã¯ãèžéªšããæ€äœãŸã§ããããŠäžèžè ãã暪éèãŸã§äŒžã³ãŠããŸãã 瞊éã«ã¯ãèžè º-MACROS-ãå¿èå¢-MACROS-ãå¿è-MACROS-ãæ°ç®¡-MACROS-ãããã³äž»èŠãªåèãšéè-MACROS-ãå«ãŸããŸãã ãŸããé£éãèžç®¡ãç¥çµç³»ã®ããŸããŸãªæ§æèŠçŽ ãªã©ã®æ§é ãèžéšã暪åã£ãŠè ¹éšã«åããéã®éè·¯ãšããŠãæ©èœããŸãã çµç¹åã®ç®ç ã®ããã«ã瞊éã¯ããã€ãã®å°ããªé å ã«åå²ãããŸãã å¿èå¢ã®åæ¹ãèžéªšäœã®åŸæ¹ã®é åãå瞊éã§ãã å¿èå¢ãšæšªéèã®åŸæ¹ãæ€äœã®åæ¹ã®é åãåŸçžŠéã§ãã å¿èå¢ãšãã®å 容ç©-MACROS-ãå«ãäžå€®ã®é å-MACROS-ãäžçžŠé-MACROS-ã§ãã 挿èå¿èïŒå¿å€èïŒã®èåŽå±€ å¿èè 挿èå¿èã®å£åŽå±€ ç·ç¶æ§å¿èã äžçžŠé 94 äžçžŠéã¯èžè ã®äžå€®ã«äœçœ®ããŸãã å¿è-MACROS-ãå¿è-MACROS-ã倧è¡ç®¡ã®èµ·å§éš-MACROS-ãããŸããŸãªç¥çµ-MACROS-ãå°è¡ç®¡-MACROS-ãå«ãŸããŸãã å¿èã¯å¿èãšå€§è¡ç®¡ã®æ ¹å ãå ãã§ããå¢ç¶ã®èã§ãã å±æ解ååŠ Â· 瞊éãäžçžŠéå¿èã¯äžçžŠéã®å¢çãå®çŸ©ãã匷éãªçµåçµç¹ã®å€å±€ã§ã -ãã¯ã-ã 挿液æ§å¿èã¯èãã2 ã€ã®éšåã§æ§æãããŠããŸããå£åŽå±€ã¯å¿èã®å é¢ãèŠã£ãŠããŸãã 挿液æ§å¿èã®èåŽå±€ïŒå¿å€èïŒã¯å¿èã«ä»çããå¿èã®å€åŽãèŠãèã圢æããŸãã 挿液æ§å¿èã®å£åŽå±€ãšèåŽå±€ã¯ã倧è¡ç®¡ïŒãã¯ãã¹ïŒã®æ ¹å ã§é£ç¶ããŠããŸãã 挿液æ§å¿èã®2å±€ã®éã«äœãããå°éã®æ¶²äœ-MACROS-ãå«ãçã空é-MACROS-ãå¿èè -MACROS-ã§ãã
Ãï¿œãã«ã¡ã¯ããŒã« 12 mg å®ãè²·ã
èºèã¯ãŸã å®å šã«ã¯çºéããŠãããïŒãã¯ãã¹ïŒãé質ãããé¡èã«ãªã£ãŠããŸãïŒãã¯ãã¹ïŒã åŠåš åŸæåŸåã®çŽ°ç®¡æã®ãã®å³ ãã¹ã¿ãŒã«ãŒãã§ã€ãã«ã¡ã¯ããŒã« 12mg ãè³Œå ¥ãã ã§ã¯ã现æ°ç®¡æ¯ãèºèã«ãªãå¢ç¶æ§é ã圢æããŠããŸãã åŠåš äžæåå-MACROS-ã§ã¯ãèå ã®èºã¯è ºæïŒç®¡ç¶æïŒã®çºé段é-MACROS-ã«ãããŸãã åŠåš 第 3 æ ã§ã¯ãå¢ç¶æã¯èºèã®çºéã®å¢å ã«ãã£ãŠç¹åŸŽä»ããããŸãã å¯Ÿç §çã«ãèºèå éé¢ã¯å®å šã«èºå®è³ªå ã§çºçããŸãã äžéšã®èºèå åé¢çã¯å 倩æ§ã§ãããå€ãã¯åçºæ§èºççºäœã䌎ã£ãŠçºçãããšèããããŠããŸãã ãã®ç å€ã¯é¡åŸ®é¡çã«ã¯è¯æ§ïŒéèª€è «ã«é¡äŒŒïŒã§ãããæ¡å€§ããŠå æ æ§ç å€ãšããŠäœçšããæ®åããæ©èœçèºå®è³ªã®åœ¢æäžå šãåŒãèµ·ãããåºçæããåŒåžå°é£ãåŒãèµ·ããå¯èœæ§ããããŸãã æ°ç®¡æ°ç®¡æ¯æš¹ãžã®æ£åžžãªæ¥ç¶ã¯ãªãããã®ã»ã°ã¡ã³ãã«ã¯å šèº«åèã®è¡æ¶²äŸçµŠããããŸãã 瀺ãããŠããç çåŠçæèŠã«ã¯ãç«æ¹äœããåæ±äžç®ã§è£æã¡ãããäžå®åœ¢ã®å¥œé žçæ§æ®éªžã§æºããããæ¡åŒµããæ°è ãåãå²ãæ ¢æ§ççã䌎ãé質ç·ç¶åããã³è¡ç®¡è¥åïŒå·Šããã«ïŒïŒå³ããã«ïŒãå«ãŸããŸãã æ£è ã¯éåžžãæ人åæã«ç²æ¶²è¿æ§ç°ã䌎ãæ ¢æ§æ¹¿æ§å³åœãšåçºæ§èºç-MACROS-ã®çç¶ãåããããã«ãªããŸãã ããã§ã®è¡ç®¡åèäŸçµŠã¯ãèºåèããã§ã¯ãªãå šèº«ããã®ãã®ã§ãããããèºã®ãã®éšåã¯æ£åžžãªé žçŽ äŸçµŠãæ©èœãããå³ããå·Šãžã®ã·ã£ã³ãæ¬ é¥ãçããããšã«ãªããŸãã éé¢ãããèºã¯è «ç€ç å€ãšããŠäœçšããå žåçã«ã¯ä¹³å æã«çç¶ãçŸããŸãã 倧ããªå¢èã¯å æ æ§ç å€ãšããŠäœçšããèºæ©èœãããã«äœäžãããå¯èœæ§ããããŸãã èºæ°è «ã¯ãèºèã®ç Žå£ã«ããèºå®è³ªã倱ãããæ®åããæ°è ãæ°žä¹ çã«æ¡åŒµããç¶æ ãç¹åŸŽãšããŸãã èºæ°è «ãé²è¡ãããšãæ¡æ£èœåã®äœäžïŒDlco ã®äœäžïŒãäœé žçŽ çãé«çé žã¬ã¹è¡çãèµ·ãããåŒåžæ§ã¢ã·ããŒã·ã¹ã«ã€ãªãããŸãã 倧ããªå¢èã«éã蟌ãããã空æ°ã¯æ»è ãšãªããæ®ã£ãèºã«è³ªéå¹æãåãŒããèºæŽ»éãããã«æžå°ããå¯èœæ§ããããŸãã ãã®å€§ããã¯ãéèè¡æ çãååšããŠããããã倧ããªèãŸãã¯éªšç€ã®éè ã«ç±æ¥ãããã®ãšäžèŽããŠããŸãã é«éœ¢è ã®åºå®åã¯æãå¯èœæ§ã®é«ããªã¹ã¯ã§ã ãããã®åé¡ã®æ ¹åºã«ã¯ååºé害ãååšããå¯èœæ§ããããŸãã è¡æ å¡æ ç-MACROS-ãç¹ã«è¥å¹Žè ã«ãããåçºæ§-MACROS-ã®å Žåã¯ãéºäŒæ§ã®ååºé害-MACROS-ã®å¯èœæ§ã瀺åããã¯ãã§ãã æªæ§è «çã«äŒŽãååºäº¢é²ç¶æ ãèªå·±å ç«çŸæ£ã«äŒŽãæãªã³è質çå矀ãªã©ã®åŸå€©çãªæ¬ é¥ãååšããå¯èœæ§ããããŸãã å€æ°ã®å°ããªæ«æ¢¢è¡æ å¡æ çãããå Žåãè¡ç®¡åºãæžå°ããèºé«è¡å§çãçºçããå¯èœæ§ããããŸãã ã»ãšãã©ã®æ£è ã¯ãææçã移æ€æ絶åå¿ãªã©ã®æ ¹æ¬çãªç æ°ã®æ²»çãšãã³ã«ãã³ã¹ããã€ãçæ³ã®äœ¿çšã«ãã£ãŠæ¹åããŸãã ç«æ¹äœç¶ã®èºèäžç®çŽ°èã䞊ã¶æ¡åŒµããæ°è ãæºãããã¯ããã¡ãŒãžãå€æ°ååšããŸã (å·Šããã«)ã ãã®ãããªäººã®ãã¡ãçŽ 1% ã®ã¿ãã-MACROS- æææ§èºçŸæ£ ã«ã€ãªããé床ã®èºç·ç¶çãæ£ã£ãŠããŸãã çµæ¶ã¯ãæ³šå ¥ãããè¬å€ãåžéããããã«äœ¿çšãããã¿ã«ã¯ãŸãã¯ãã®ä»ã®ç¡æ©ç©è³ªãè¡šããŸãã ããã«ãããååºéšåã®æ¥µç«¯ã«é»è²ãå€èŠ³ã«åºã¥ãããããããé»éãèºçãçºçããå¯èœæ§ããããŸãã ã«ã³ãžãã¯ã现èæ§èºçã«èçŒçã«é¡äŒŒããèºçãçšã«åŒãèµ·ããããšããããå ç«äžå šå®¿äž»ã§ããé »ç¹ã«çºçããŸãã å€ãã®å Žåãåç°æ¡åãæ°ç®¡æ¯é¡æ€æ»ãªã©ã®èšºææè¡ã§åŸããã现è蚺æšæ¬ã«çŸããåºèœçŽ°èãä»®æ§è糞ã¯å£è åœé ã®æ±æç©è³ªã§ãããäžæ°éææçã瀺ãå¯èœæ§ã¯äœãã ããã§ã®ææå åã¯ãæ ¢æ§ã®è¿çæ§ççãåŒãèµ·ããããšãç¥ãããŠãããã«ã«ãžã¢ã»ãã©ãžãªãšã³ã·ã¹ïŒãã¯ãã¹ïŒã§ãã äŸµå ¥å£ã¯èºã§ãããææã¯ä»ã®å Žæã«åºããå¯èœæ§ããããå€ãã®å Žåãè³ã«åºãããŸãã å³ã®ããã«-MACROS-ã®é«åçã§ã¯ã糞ç¶ããã³ããŒãºç¶ã® Nocardia asteroides 埮çç©ããã«ã€ãžã³ ãã«ãŒæè²-MACROS-ã§ç¢ºèªã§ããŸãã ãããã¯ããããåå¿æ§ã§ããè «çæ§ã§ã¯ãªã ã§ãããäž»ã«é«éœ¢å¥³æ§ã«èŠãããèšåºçæ矩ã¯ãªã ã å³ã®ããã« ã®æµžæœ€å¢çãšãå·Šã®ããã« ã®ããå€åœ¢æ§ãšéæè²æ§ã匷ãããã€ãã®çŽ°èã«æ³šæããŠãã ããã ãããã¯åãå ŽæïŒæ°ç®¡æ¯ïŒã«çºçããŸãããå žåçãªã«ã«ããã€ããããæ«æ¢¢æ§ã§ããå¯èœæ§ãé«ããªããŸãã ãã®ã³ã€ã³ç¶ç å€ã®éå¥èšºæã«ã¯ãèèœè «ãçè «ãéèª€è « ãå«ãŸããŸãã å€ç«æ§èºçµç¯ã¯ãèºå®è³ªã«å®å šã«å²ãŸããèºéã瞊éã«æ¥ãããçŽåŸã 3 cm æªæºã®ãæ確ãªå¢çãæã€å€ç«ããäžžãäžéæéšã§ãã ãã®ãããªç å€ã¯ããªã³ãç¯è «è¹-MACROS-ãç¡æ°èº-MACROS-ããŸãã¯èžæ°Ž-MACROS-ãšã¯é¢é£ããããŸããã ããæããçžãæã€å€§ããªãªã³ãç¯ãå³äž»æ°ç®¡æ¯ã«è¡çªããå±æçãªå§è¿« ãåŒãèµ·ãããŸãã ã»ãšãã©ã®å Žåã现èæ§å ç«åå¿ã«ãã£ãŠææãæå¶ãããæ°å¹ŽåŸã«ã¯å±æçãªç³ç°åã ããæ®ãå¯èœæ§ããããŸãã èåŸéšã®å°ããªãžãã¿ã¯ãéåããç²è žå ãè¡šããŠããŸãã 糞ç¶ä¹³é ã¯äžé¢ã«ãã«ãããã®ãããªè³ªæãäžããæ»ãåãæ©èœãå¯èœã«ããŸãã èžç¶ä¹³é ã¯äžžãè¡šé¢ãæã¡ãè§è³ªåããŠããªããããèã®èã«èµ€ãç¹æš¡æ§ã®ããã«èŠããé¢é£ããå³èŸãæã£ãŠããŸãã
12mgã€ãã«ã¡ã¯ããŒã«ã¯å¹æç
ãã¶ã§ã€ãã«ã¡ã¯ããŒã« 12 mg ã泚æãã
å®ãã€ãã«ã¡ã¯ããŒã« 12mg OTC
ã€ãã«ã¡ã¯ããŒã« 12mg ããªã³ã©ã€ã³ã§å²åŒ
å²åŒäŸ¡æ Œã§ã€ãã«ã¡ã¯ããŒã« 12 mg ããªã³ã©ã€ã³ã§è³Œå
¥